Tularemia

Infectious Disease Clinics of North America

Volumn 22, Issue 3, 2008, Pages 489-504

  Nigrovic, Lise E ^a,b   Wingerter, Sarah L ^c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; LIVE VACCINE; STREPTOMYCIN; TETRACYCLINE; TULAREMIA VACCINE;

ANTIBIOTIC THERAPY; BACTERIUM IDENTIFICATION; BIOLOGICAL WARFARE; CLINICAL FEATURE; DISEASE CARRIER; DISEASE TRANSMISSION; ENAMEL; ENDEMIC DISEASE; EPIDEMIC; FRANCISELLA TULARENSIS; GEOGRAPHIC DISTRIBUTION; HARE; HISTORY OF MEDICINE; HUMAN; INFECTION PREVENTION; MORBIDITY; MUSKRAT; NONHUMAN; PATHOGENESIS; PNEUMONIA; PREVALENCE; RABBIT; REVIEW; SIDE EFFECT; SKIN ULCER; TULAREMIA;

ANIMALS; ARTHROPOD VECTORS; BIOTERRORISM; DIPTERA; DISEASE RESERVOIRS; FRANCISELLA TULARENSIS; HUMANS; RODENTIA; SEASONS; TICK-BORNE DISEASES; TICKS; TULAREMIA; UNITED STATES; ZOONOSES;

EID: 49849083789     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2008.03.004     Document Type: Review

References (69)

1. Scheel O., Sandvik T., Hoel T., et al. [Tularemia in Norway. A clinical and epidemiological review]. Tidsskr Nor Laegeforen 112 5 (1992) 635-637 [in Norwegian]
2. Morner T. The ecology of tularaemia. Rev Sci Tech 11 4 (1992) 1123-1130
3. Pearse R.A. Insect bites. Northwest Med 3 (1911) 81-82
4. Ohara S. Studies on yato-byo (Ohara's disease, tularemia in Japan). I. Jpn J Exp Med 24 (1954) 69-79
5. McCoy G.W., and Chapin C.W. Further observations on a plague-like disease of rodents with a preliminary note on the causative agent, Bacterium tularense. J Infect Dis 10 (1912) 61-72
6. Wherry W.B., and Lamb B.H. Infection of man with Bacterium tularense. J Infect Dis 15 (1914) 331-340
7. Ohara H. Human inoculation experiment with a disease of wild rabbits, with a bacteriologic study. Kinsei Igaku (1925) 401
8. Francis E. A summary of the present knowledge of tularemia. Medicine (Baltimore) 7 (1928) 411-432
9. Francis E. Tularemia. JAMA 84 (1925) 1243-1250
10. Keim P., Johansson A., and Wagner D.M. Molecular epidemiology, evolution, and ecology of Francisella. Ann N Y Acad Sci 1105 (2007) 30-66
11. Gurycova D. First isolation of Francisella tularensis subsp. tularensis in Europe. Eur J Epidemiol 14 8 (1998) 797-802
12. Evans M.E. Francisella tularensis. Infect Control 6 9 (1985) 381-383
13. Metzger D.W., Bakshi C.S., and Kirimanjeswara G. Mucosal immunopathogenesis of Francisella tularensis. Ann N Y Acad Sci 1105 (2007) 266-283
14. Sjostedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 1105 (2007) 1-29
15. Francis E. Symptoms, diagnosis and pathology of tularemia. JAMA 91 (1928) 1155-1161
16. Suvarov S., Volfertz V., and Voronkova M.M. Plague like lymphadenitis of the Astrikhansky Region. Vestnik Mikrobiol Epidemiol Parazitol 7 (1928) 293
17. Zarkai G.I. Tularemia among water rats; methods of studying them. Bull Hyg 5 (1930) 875
18. Francis E. Sources of infection and seasonal incidence of tularemia in man. Public Health Rep 52 (1937) 103-113
19. Weinberg A.N. Commentary: Wherry WB, Lamb BH. Infection of man with Bacterium tularense. J Infect Dis 1914;15:331-340. J Infect Dis 189 7 (2004) 1317-1320
20. Tularemia-United States, 1990-2000. MMWR Morb Mortal Wkly Rep 51 9 (2002) 181-184
21. Jellison W.L. Tularemia in North America, 1930-1974 (1974), University of Montana, Missoula (MT)
22. Petersen J.M., and Schriefer M.E. Tularemia: emergence/re-emergence. Vet Res 36 3 (2005) 455-467
23. Young L.S., Bicknell D.S., and Archer B.G. Tularemia epidemic: Vermont, 1968. Forty-seven cases linked to contact with muskrats. N Engl J Med 280 (1969) 1253-1260
24. Avashia S.B., Petersen J.M., Lindley C.M., et al. First reported prairie dog-to-human tularemia transmission, Texas, 2002. Emerg Infect Dis 10 3 (2004) 483-486
25. Feldman K.A., Enscore R.E., Lathrop S.L., et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med 345 22 (2001) 1601-1606
26. Tularemia associated with a hamster bite-Colorado, 2004. MMWR Morb Mortal Wkly Rep 53 51 (2005) 1202-1203
27. Capellan J., and Fong I.W. Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis 16 4 (1993) 472-475
28. Liles W.C., and Burger R.J. Tularemia from domestic cats. West J Med 158 6 (1993) 619-622
29. Sandstrom G., Sjostedt A., Johansson T., et al. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol Immunol 5 4 (1992) 201-210
30. Chen W., KuoLee R., Shen H., et al. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. Microb Pathog 36 6 (2004) 311-318
31. Balagopal A., MacFarlane A.S., Mohapatra N., et al. Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 74 9 (2006) 5114-5125
32. Bosio C.M., Bielefeldt-Ohmann H., and Belisle J.T. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 178 7 (2007) 4538-4547
33. Anthony L.S., Skamene E., and Kongshavn P.A. Influence of genetic background on host resistance to experimental murine tularemia. Infect Immun 56 8 (1988) 2089-2093
34. Quan S.F., McManus A.G., and Von Fintel H. Infectivity of tularemia applied to intact skin and ingested in drinking water. Science 123 3204 (1956) 942-943
35. Ohara Y., Sato T., Fujita H., et al. Clinical manifestations of tularemia in Japan-analysis of 1,355 cases observed between 1924 and 1987. Infection 19 1 (1991) 14-17
36. Ellis J., Oyston P.C., Green M., et al. Tularemia. Clin Microbiol Rev 15 4 (2002) 631-646
37. Sandstrom G., Lofgren S., and Tarnvik A. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun 56 5 (1988) 1194-1202
38. Evans M.E., Gregory D.W., Schaffner W., et al. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 64 4 (1985) 251-269
39. Pullen R.L., and Stuart B.M. Tularemia, an analysis of one-hundred forty-seven cases. JAMA 129 (1945) 495-500
40. Giddens W.R., Wilson Jr. J.W., Dienst Jr. F.T., et al. Tularemia; an analysis of one hundred forty-seven cases. J La State Med Soc 109 3 (1957) 93-98
41. Sanders C.V., and Hahn R. Analysis of 106 cases of tularemia. J La State Med Soc 120 9 (1968) 391-393
42. Hughes W.T., and Etteldorf J.N. Oropharyngeal tularemia. J Pediatr 51 (1957) 363-372
43. Levy H.B., Webb C.H., and Wilkinson J.D. Tularemia as a pediatric problem. Pediatrics 6 1 (1950) 113-123
44. Everett E.D., and Templer J.W. Oropharyngeal tularemia. Arch Otolaryngol 106 4 (1980) 237-238
45. Foshay L. A summary of certain aspects of the disease including methods for early diagnosis and the results of serum treatment in 600 patients. Medicine 19 (1940) 1-83
46. Matyas B.T., Nieder H.S., and Telford III S.R. Pneumonic tularemia on Martha's Vineyard: clinical, epidemiologic, and ecological characteristics. Ann N Y Acad Sci 1105 (2007) 351-377
47. Feldman K.A., Stiles-Enos D., Julian K., et al. Tularemia on Martha's Vineyard: seroprevalence and occupational risk. Emerg Infect Dis 9 3 (2003) 350-354
48. Sato T., Fujita H., Ohara Y., et al. Microagglutination test for early and specific serodiagnosis of tularemia. J Clin Microbiol 28 10 (1990) 2372-2374
49. Saslaw S., and Carhart S. Studies with tularemia vaccines in volunteers. III. Serologic aspects following intracutaneous or respiratory challenge in both vaccinated and nonvaccinated volunteers. Am J Med Sci 241 (1961) 689-699
50. Ransmeier J.C., and Ewing C.L. The agglutination reaction in tularemia. J Infect Dis 69 (1941) 193-205
51. Koskela P., and Herva E. Cell-mediated immunity against Francisella tularensis after natural infection. Scand J Infect Dis 12 4 (1980) 281-287
52. Hotta A., Uda A., Fujita O., et al. Preparation of monoclonal antibodies for detection and identification of Francisella tularensis. Clin Vaccine Immunol 14 1 (2007) 81-84
53. Johansson A., Berglund L., Eriksson U., et al. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 38 1 (2000) 22-26
54. Eliasson H., Sjostedt A., and Back E. Clinical use of a diagnostic PCR for Francisella tularensis in patients with suspected ulceroglandular tularaemia. Scand J Infect Dis 37 11-12 (2005) 833-837
55. Overholt E.L., Tigertt W.D., Kadull P.J., et al. An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics. Am J Med 30 (1961) 785-806
56. Lawler A. Biodefense labs. Boston University under fire for pathogen mishap. Science 307 5709 (2005) 501
57. Dalton R. Infection scare inflames fight against biodefence network. Nature 433 7024 (2005) 344
58. Burkhardt J.E., Walterspiel J.N., and Schaad U.B. Quinolone arthropathy in animals versus children. Clin Infect Dis 25 5 (1997) 1196-1204
59. Chalumeau M., Tonnelier S., D'Athis P., et al. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics 111 6 Pt 1 (2003) e714-e719
60. Forsythe C.T., and Ernst M.E. Do fluoroquinolones commonly cause arthropathy in children. CJEM 9 6 (2007) 459-462
61. Kashyap A.S., and Sharma H.S. Discolouration of permanent teeth and enamel hypoplasia due to tetracycline. Postgrad Med J 75 890 (1999) 772
62. Enderlin G., Morales L., Jacobs R.F., et al. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 19 1 (1994) 42-47
63. Saslaw S., Eigelsbach H.T., Prior J.A., et al. Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med 107 (1961) 702-714
64. Saslaw S., Eigelsbach H.T., Wilson H.E., et al. Tularemia vaccine study. I. Intracutaneous challenge. Arch Intern Med 107 (1961) 689-701
65. Burke D.S. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 135 1 (1977) 55-60
66. Sandstrom G. The tularaemia vaccine. J Chem Technol Biotechnol 59 4 (1994) 315-320
67. Dennis D.T., Inglesby T.V., Henderson D.A., et al. Tularemia as a biological weapon: medical and public health management. JAMA 285 21 (2001) 2763-2773
68. Christopher G.W., Cieslak T.J., Pavlin J.A., et al. Biological warfare. A historical perspective. JAMA 278 5 (1997) 412-417
69. Forestal C.A., Benach J.L., Carbonara C., et al. Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J Immunol 171 5 (2003) 2563-2570